By applying a reverse translational approach that evaluates compounds with emerging clinical efficacy, we demonstrated that semaglutide, tirzepatide, and retatrutide blunt alcohol interoceptive/subjective effects, potentially clarifying a clinically meaningful mechanism
The SUSTAIN 29,30,31,32,33,34,35 and SCALE studies 10,11,12,13,14,15 have shown robust efficacy in lowering blood glucose levels in diabetic patients and inducing weight loss in obese patients over clinical trial periods ranging from 30 to 104 weeks
Final Thoughts GLP-1 medications are a powerful toolbut theyre not a magic bullet
Even though Lilly is the same company behind Zepbound, the blockbuster injectable obesity medicine, Eli Lilly decided not to take Zepbound's main ingredient and make it in pill form
Thiol proteins, redox modulation and parenchymal lung disease
A., White, B